Post Categories
QPS Study Shows Estetrol Promising for Prostate Cancer Treatment
May 2, 2017
An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels…
QPS Sponsors Day 1 of World ADC Meeting in Berlin
February 20, 2017
QPS is the main sponsor of the Analytical and Bioanalytical Day at the 7th World ADC Meeting, February 20 – 22, 2017 at the…
QPS Assay Finder Database Grows 47 New Assays!
November 28, 2016
For all you assay aficionados out there, we thought you’d be juiced to know — we just added a whopping 47 new assays to…
Client Feedback — Our Gold Standard
December 13, 2016
At QPS, we love making customers happy. Here’s what two of them had to say about our work in DMPK protein binding studies: First…
QPS Is Eastern Minority Supplier Development Council (EMSDC) 2016 Class IV Supplier of the Year
December 5, 2016
For outstanding performance including growth in sales, continuous growth in minority business to minority business purchases, innovation in the delivery of services, significant and…
Sanjay Mitter new VP and Global Head of Clinical Research Services
September 14, 2016
Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics,…
Let’s Talk Neuro at the AAIC 2016 in Toronto, Canada, July 24-27, 2016
July 19, 2016
Join us from July 24-27, 2016 in Toronto, Canada for the Alzheimer’s Association International Conference. QPS neuroscientists will attend the AAIC 2016 and would…
QPS Netherlands scientist Daniel Wilffert nominated for New Investigator Award by Bioanalysis Zone!
June 22, 2016
Since 2012, a New Investigator Award has been given annually to honor excellence among bioanalytical scientists within their first five years in the industry….
We are exhibiting at the DIA 2016 Annual Meeting at our booth #1200 between June 26-30 at Philadelphia, PA, USA.
June 21, 2016
We are exhibiting at the DIA 2016 Annual Meeting at our booth #1200 between June 26-30 at Philadelphia, PA, USA. If you are attending…
Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia!
May 17, 2016
QPS CEO Ben Chien has made it through to the round of 30 (31, actually) being considered for this year’s prestigious EY Entrepreneur Of…
Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability
May 17, 2016
Each year, Life Science Leader honors CROs that are the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. To determine the winners, the…
QPS’ Patient Recruitment Management at the 2016 Annual Meeting of the Clinical Trials Community in Israel
May 4, 2016
Patient recruitment is one of the most critical foundations of any clinical trial. Effective patient recruitment sets the trial down a path toward success…
Changing Our Perspective on “Mind-Altering” Drugs – Part II
July 19, 2022
Developing an effective and safe medicine is a labor of love in any therapeutic area, but perhaps none so much as the central nervous…
Brain Implant Enables Communication in ALS Patient
June 29, 2022
As many as 30,000 people in the United States are currently diagnosed with amyotrophic lateral sclerosis, or ALS. This debilitating neurological condition is caused…
Changing Our Perspective on “Mind-Altering” Drugs – Part I
June 28, 2022
For a generation that grew up with “Just Say No” as a recurring theme, the idea of taking psychedelics with nicknames such as acid…
New Obesity Drug Shows Great Promise in Phase III Trials
June 22, 2022
Danish pharmaceutical giant Novo Nordisk changed the game last year, presenting data that suggested one of the company’s diabetes drugs was also highly effective…
Could a New Gap-Free Human Genome Make Personal DNA Sequencing “Routine” Care?
June 20, 2022
In 2003, while recognizing the 50th anniversary of the discovery of the double helix, researchers announced that the human genome had been sequenced —…
The Potential of a Self-Amplifying mRNA Vaccine Is Heard Loud and Clear
June 13, 2022
Thanks in large part to the efficacy of the Pfizer-BioNTech and Moderna mRNA vaccines, mask mandates, social distancing, and other COVID-19-related precautions have eased…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
